Clin2
NCT06959199Possibly a fitRecruiting

Treating stroke beyond 24 hours with artery-opening procedure

StrokeCerebrovascular DisordersBrain DiseasesNervous System DiseasesVascular DiseasesIschemic StrokeInfarction

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests whether opening a blocked large artery in the brain up to 5 days (or even 7 days if symptoms are worsening) after a stroke can improve outcomes. It uses a catheter-based treatment (endovascular therapy) for people who have not responded to standard care and have limited brain damage so far.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
432 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your stroke symptoms started between 24 hours and 5 days ago (or up to 7 days if symptoms were getting worse).
  • Your stroke symptoms are rated moderate to moderately severe (NIHSS score 5–25).
  • Brain scans show a severe blockage (70% or more) in the carotid or middle cerebral artery, but the stroke damage is not too extensive.
  • You have not had a prior stroke that left you with significant disability (mRS score less than 2).
  • You do not have conditions that increase bleeding risk, like low platelets, blood thinner use with high INR, or recent bleeding in the brain.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06633809Recruiting
Treating minor stroke with large artery blockage

This study tests whether a specific treatment (likely endovascular therapy) helps people who have a minor stroke caused by a blockage in a large brain artery. If you are eligible, you may receive this treatment within 24 hours of your stroke to try to improve your recovery.

Hangzhou, Zhejiang
NCT07495969Not yet recruiting
Opening blocked brain arteries to prevent more strokes

This study tests a procedure called endovascular recanalization, which uses a small tube to open a blocked artery in the brain. It is for people who had a stroke or mini-stroke recently and are still having symptoms despite taking medication. The goal is to improve blood flow and reduce the chance of another stroke.

Beijing, Beijing Municipality
NCT07476898Not yet recruiting· Phase 3
Reperfusion therapy for disabling minor stroke with large vessel blockage

This trial tests a precise treatment to restore blood flow in people who had a mild but disabling stroke up to 24 hours earlier, using mechanical clot removal or clot-busting medication. The goal is to reduce long-term disability by reopening the blocked vessel while protecting healthy brain tissue.

Fuzhou, Fujian
NCT07843836Not yet recruiting
Clot removal versus medication for late stroke treatment

This trial compares a procedure to remove a blood clot from a brain artery (endovascular therapy) with standard medicines alone, for people who had a large-vessel stroke more than 24 hours ago (up to 30 days). It aims to see if the procedure can still help improve recovery even after this longer time window, especially if symptoms are fluctuating or worsening.

Beijing, Beijing Municipality
NCT07232082Not yet recruiting
Cooling and reopening blocked arteries for severe stroke

This trial tests whether cooling the brain and reopening a blocked major artery can improve recovery after a severe stroke. It is for people who have had a large stroke and may benefit from this combination treatment.

NCT06472336Recruiting
Stenting for severe stroke caused by plaque buildup

This trial tests whether placing a stent (a tiny tube) in the blocked artery in the brain can improve blood flow and help people recover from a severe stroke, especially when standard clot removal has not worked.

Basel, Canton of Basel-City

Hear when a new Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.